UFF
IDXX icon

USA Financial Formulas’s Idexx Laboratories IDXX Stock Holding History

USA Financial Formulas’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18K Sell
32
-2,045
-98% -$1.31M ﹤0.01% 268
2025
Q4 		$1.41M Sell
2,077
-1,650
-44% -$1.12M 0.26% 28
2025
Q3 		$2.38M Buy
+3,727
New +$2.26M 0.42% 22
2024
Q2 		– Sell
-1,501
Closed -$810K – 340
2024
Q1 		$810K Buy
1,501
+1,475
+5,673% +$806K 0.13% 87
2023
Q4 		$14.4K Sell
26
-383
-94% -$180K ﹤0.01% 244
2023
Q3 		$179K Buy
409
+408
+40,800% +$203K 0.27% 98
2023
Q2 		$502 Hold
1
– – ﹤0.01% 429
2023
Q1 		$500 Buy
+1
New +$479 ﹤0.01% 364
2022
Q3 		$0 Hold
1
– – ﹤0.01% 354
2022
Q2 		$0 Hold
1
– – ﹤0.01% 382
2022
Q1 		$1K Hold
1
– – ﹤0.01% 304
2021
Q4 		$1K Sell
1
-1,688
-100% -$1.06M ﹤0.01% 322
2021
Q3 		$1.05M Sell
1,689
-203
-11% -$136K 0.94% 51
2021
Q2 		$1.2M Sell
1,892
-1,608
-46% -$888K 1% 23
2021
Q1 		$1.71M Sell
3,500
-1,175
-25% -$589K 1.39% 11
2020
Q4 		$2.34M Sell
4,675
-1,664
-26% -$745K 1.85% 9
2020
Q3 		$2.49M Buy
+6,339
New +$2.34M 1.88% 15
2019
Q1 		– Sell
-34,410
Closed -$8.59M – 223
2018
Q4 		$8.59M Buy
+34,410
New +$7.05M 2.14% 8
2018
Q3 		– Sell
-2,171
Closed -$416K – 329
2018
Q2 		$416K Sell
2,171
-10
-0.5% -$2.06K 0.1% 165
2018
Q1 		$417K Buy
+2,181
New +$403K 0.1% 166
2017
Q3 		– Sell
-39,372
Closed -$6.36M – 289
2017
Q2 		$6.36M Buy
+39,372
New +$6.39M 1.53% 14
2017
Q1 		– Sell
-5,779
Closed -$678K – 283
2016
Q4 		$678K Sell
5,779
-5,432
-48% -$620K 0.17% 98
2016
Q3 		$1.26M Buy
+11,211
New +$1.18M 0.32% 73
2015
Q1 		– Sell
-5,334
Closed -$395K – 208
2014
Q4 		$395K Buy
+5,334
New +$374K 0.14% 157

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

USA Financial Formulas's IDXX Position: Q1 2026 in Review

USA Financial Formulas reduced its Idexx Laboratories (IDXX) stake by 98% in Q1 2026, selling an estimated $1.31M and leaving 32 shares worth $18K. The position accounts for ﹤0.01% of the portfolio, ranked #268.

USA Financial Formulas first reported a position in IDXX in Q4 2014 and has held it in 24 quarters since. The position peaked at $8.59M in Q4 2018. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • USA Financial Formulas held 32 shares of Idexx Laboratories worth $18K as of Q1 2026.
  • USA Financial Formulas sold 2,045 Idexx Laboratories shares in Q1 2026, an estimated $1.31M.
  • Idexx Laboratories made up ﹤0.01% of USA Financial Formulas's portfolio in Q1 2026, its #268 holding.
  • USA Financial Formulas first reported a position in Idexx Laboratories in Q4 2014 and has held it in 24 quarters since.
  • USA Financial Formulas's Idexx Laboratories position peaked at $8.59M in Q4 2018.
  • 1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on USA Financial Formulas's 13F filing for Q1 2026, filed 14 Apr 2026.